Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated ; volume:18 ; number:1 ; day:11 ; month:5 ; year:2020 ; pages:1-9 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (11.5.2020), 1-9, 12.2020

Creator
Al Hashmi, Muna
Sastry, Konduru S.
Silcock, Lee
Chouchane, Lotfi
Mattei, Valentina
James, Nicola
Mathew, Rebecca
Bedognetti, Davide
De Giorgi, Valeria
Murtas, Daniela
Liu, Wei
Chouchane, Aouatef
Temanni, Ramzi
Seliger, Barbara
Wang, Ena
Marincola, Francesco M.
Tomei, Sara
Contributor
SpringerLink (Online service)

DOI
10.1186/s12967-020-02350-8
URN
urn:nbn:de:101:1-2020071707551308458166
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Al Hashmi, Muna
  • Sastry, Konduru S.
  • Silcock, Lee
  • Chouchane, Lotfi
  • Mattei, Valentina
  • James, Nicola
  • Mathew, Rebecca
  • Bedognetti, Davide
  • De Giorgi, Valeria
  • Murtas, Daniela
  • Liu, Wei
  • Chouchane, Aouatef
  • Temanni, Ramzi
  • Seliger, Barbara
  • Wang, Ena
  • Marincola, Francesco M.
  • Tomei, Sara
  • SpringerLink (Online service)

Other Objects (12)

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

Translational medicine from observation to hypothesis to interpretation

Translational medicine from observation to hypothesis to interpretation

RNA amplification for successful gene profiling analysis

RNA amplification for successful gene profiling analysis

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma

BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism

BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report

Changing paradigm through a genome-based approach to clinical and basic immunology

Changing paradigm through a genome-based approach to clinical and basic immunology

Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling

Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling

Related objects